<p>Cresco Labs Inc.（OTCMKTS:CRLBF - 獲取免費報告）在週三的交易中創下了 52 周的新高。該股最高交易價格為 1.99 美元，最後交易價格為 1.93 美元，成交量為 910976 股。該股此前收盤價為 1.7541 美元。</p>
<h2>分析師評級調整</h2>
<p>多家研究公司最近對 CRLBF 進行了評估。ATB Capital 在 12 月 2 日的報告中將 Cresco Labs 的評級上調至 “跑贏大盤”。Atb Cap Markets 在 12 月 2 日的研究報告中將 Cresco Labs 的評級從 “持有” 上調至 “強力買入”。最後，Zacks Research 在 11 月 12 日的研究報告中將 Cresco Labs 的評級從 “強烈賣出” 上調至 “持有”。一位分析師給予該股 “強力買入” 評級，一位給予 “買入” 評級，一位給予 “持有” 評級。根據 MarketBeat 的數據，該公司的共識評級為 “買入”。</p>
<p><strong>查看我們關於 CRLBF 的最新股票報告</strong></p>
<h2>Cresco Labs 股票表現</h2>
<p>該公司的債務股本比率為 1.28，流動比率為 2.49，速動比率為 1.54。該股的 50 日移動平均價格為 1.06 美元，200 日移動平均價格為 0.93 美元。該公司的市值為 6.6915 億美元，市盈率為-12.53，貝塔值為 1.55。</p>
<p>Cresco Labs（OTCMKTS:CRLBF - 獲取免費報告）最近於 11 月 7 日發佈了季度財報。該公司報告季度每股收益（EPS）為-0.05 美元，低於分析師的共識預期-0.03 美元，差額為-0.02 美元。Cresco Labs 的股本回報率為-14.25%，淨利潤率為-7.79%。該季度的營業收入為 1.65 億美元，而共識預期為 1.6374 億美元。股票分析師預計 Cresco Labs Inc.在當前年度將發佈-0.2 美元的每股收益。</p>
<h2>關於 Cresco Labs</h2>
<p>（獲取免費報告）</p>
<p>Cresco Labs Inc 及其子公司在美國從事零售和醫療大麻產品的種植、製造和銷售。它提供以 Cresco 品牌銷售的花朵、大麻蒸汽筆、活性樹脂、一次性筆和提取物；以 High Supply 品牌銷售的蒸汽罐、蒸汽筆、花朵、爆米花、搖晃、預卷、短卷和濃縮物；以 Good News 品牌銷售的蒸汽和軟糖；以 Wonder Wellness Co 品牌銷售的蒸汽和食品；以及以 Remedi 品牌銷售的酊劑、膠囊、藥膏和舌下油。</p>
<h2>推薦故事</h2>
<ul>
<li>我們更看好的五隻股票比 Cresco Labs 更好</li>
<li>每股收益計算器：如何計算 EPS</li>
<li>工業領域的大規模突破：現在必須關注的三隻股票</li>
<li>什麼是股息挑戰者？</li>
<li>三隻科技股下跌超過 60%——哪一隻值得購買？</li>
<li>投資者需要知道的以戰勝市場的信息</li>
<li>25 年後，思科終於從互聯網泡沫崩潰中恢復過來</li>
</ul>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1000 美元在 Cresco Labs 嗎？</h2>
<p>在考慮 Cresco Labs 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而 Cresco Labs 並不在名單上。</p>
<p>雖然 Cresco Labs 目前在分析師中獲得 “買入” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

CRLBF

<p>Cresco Labs（OTCMKTS:CRLBF）達到了新的 52 周高點，交易價格高達 1.99 美元。分析師們對該股票進行了升級，ATB Capital 和 Atb Cap Markets 分別給予了 “跑贏大盤” 和 “強力買入” 的評級。儘管每股收益為負且股本回報率不佳，該公司在本季度報告了 1.65 億美元的收入。Cresco Labs 的共識評級為 “買入”，但頂級分析師建議其他股票可能是更好的投資選擇</p>

<p>Cresco Labs Inc. (OTCMKTS:CRLBF - Get Free Report) hit a new 52-week high during trading on Wednesday . The stock traded as high as $1.99 and last traded at $1.93, with a volume of 910976 shares. The stock had previously closed at $1.7541.</p>
<div class="lb-trans"><p>Cresco Labs Inc.（OTCMKTS:CRLBF - 獲取免費報告）在週三的交易中創下了 52 周的新高。該股最高交易價格為 1.99 美元，最後交易價格為 1.93 美元，成交量為 910976 股。該股此前收盤價為 1.7541 美元。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師評級調整</h2>
</div><p>A number of research firms recently weighed in on CRLBF. ATB Capital raised Cresco Labs to an &#34;outperform&#34; rating in a report on Tuesday, December 2nd. Atb Cap Markets upgraded shares of Cresco Labs from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research note on Tuesday, December 2nd. Finally, Zacks Research upgraded shares of Cresco Labs from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research note on Wednesday, November 12th. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of &#34;Buy&#34;.</p>
<div class="lb-trans"><p>多家研究公司最近對 CRLBF 進行了評估。ATB Capital 在 12 月 2 日的報告中將 Cresco Labs 的評級上調至 “跑贏大盤”。Atb Cap Markets 在 12 月 2 日的研究報告中將 Cresco Labs 的評級從 “持有” 上調至 “強力買入”。最後，Zacks Research 在 11 月 12 日的研究報告中將 Cresco Labs 的評級從 “強烈賣出” 上調至 “持有”。一位分析師給予該股 “強力買入” 評級，一位給予 “買入” 評級，一位給予 “持有” 評級。根據 MarketBeat 的數據，該公司的共識評級為 “買入”。</p>
</div><p><strong>View Our Latest Stock Report on CRLBF</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 CRLBF 的最新股票報告</strong></p>
</div><h2>Cresco Labs Stock Performance</h2>
<div class="lb-trans"><h2>Cresco Labs 股票表現</h2>
</div><p>The company has a debt-to-equity ratio of 1.28, a current ratio of 2.49 and a quick ratio of 1.54. The stock's 50-day moving average price is $1.06 and its 200-day moving average price is $0.93. The company has a market cap of $669.15 million, a P/E ratio of -12.53 and a beta of 1.55.</p>
<div class="lb-trans"><p>該公司的債務股本比率為 1.28，流動比率為 2.49，速動比率為 1.54。該股的 50 日移動平均價格為 1.06 美元，200 日移動平均價格為 0.93 美元。該公司的市值為 6.6915 億美元，市盈率為-12.53，貝塔值為 1.55。</p>
</div><p>Cresco Labs (OTCMKTS:CRLBF - Get Free Report) last released its quarterly earnings results on Friday, November 7th. The company reported ($0.05) EPS for the quarter, missing analysts' consensus estimates of ($0.03) by ($0.02). Cresco Labs had a negative return on equity of 14.25% and a negative net margin of 7.79%.The business had revenue of $165.00 million for the quarter, compared to the consensus estimate of $163.74 million. Equities analysts anticipate that Cresco Labs Inc. will post -0.2 EPS for the current year.</p>
<div class="lb-trans"><p>Cresco Labs（OTCMKTS:CRLBF - 獲取免費報告）最近於 11 月 7 日發佈了季度財報。該公司報告季度每股收益（EPS）為-0.05 美元，低於分析師的共識預期-0.03 美元，差額為-0.02 美元。Cresco Labs 的股本回報率為-14.25%，淨利潤率為-7.79%。該季度的營業收入為 1.65 億美元，而共識預期為 1.6374 億美元。股票分析師預計 Cresco Labs Inc.在當前年度將發佈-0.2 美元的每股收益。</p>
</div><h2>About Cresco Labs</h2>
<div class="lb-trans"><h2>關於 Cresco Labs</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.</p>
<div class="lb-trans"><p>Cresco Labs Inc 及其子公司在美國從事零售和醫療大麻產品的種植、製造和銷售。它提供以 Cresco 品牌銷售的花朵、大麻蒸汽筆、活性樹脂、一次性筆和提取物；以 High Supply 品牌銷售的蒸汽罐、蒸汽筆、花朵、爆米花、搖晃、預卷、短卷和濃縮物；以 Good News 品牌銷售的蒸汽和軟糖；以 Wonder Wellness Co 品牌銷售的蒸汽和食品；以及以 Remedi 品牌銷售的酊劑、膠囊、藥膏和舌下油。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推薦故事</h2>
</div><ul>
<li>Five stocks we like better than Cresco Labs</li>
<li>Earnings Per Share Calculator: How to Calculate EPS</li>
<li>Massive Breakout in Industrials: 3 Must-Watch Stocks Now</li>
<li>What Are Dividend Challengers?</li>
<li>3 Tech Stocks Down Over 60%—Which One Is Worth Buying?</li>
<li>What Investors Need to Know to Beat the Market</li>
<li>25 Years Later, Cisco Finally Recovers From the Dot-Com Crash</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票比 Cresco Labs 更好</li>
<li>每股收益計算器：如何計算 EPS</li>
<li>工業領域的大規模突破：現在必須關注的三隻股票</li>
<li>什麼是股息挑戰者？</li>
<li>三隻科技股下跌超過 60%——哪一隻值得購買？</li>
<li>投資者需要知道的以戰勝市場的信息</li>
<li>25 年後，思科終於從互聯網泡沫崩潰中恢復過來</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Cresco Labs Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在 Cresco Labs 嗎？</h2>
</div><p>Before you consider Cresco Labs, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Cresco Labs 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cresco Labs wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而 Cresco Labs 並不在名單上。</p>
</div><p>While Cresco Labs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Cresco Labs 目前在分析師中獲得 “買入” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Cresco Labs (OTCMKTS:CRLBF) 創下 52 周新高 - 現在是買入的好時機嗎？